Significance of Patient-Reported Outcomes for Metastatic Breast Cancer Patients. 4. November 2022 Hillebrand L, E, Söling U, Marschner N, 2022. Oncol Res Treat 2022;45:423-429. doi: 10.1159/000521826 Real-world patient-reported outcomes of breast cancer or prostate cancer patients receiving antiresorptive therapy for bone metastases: Final results of the PROBone registry study. A Jakob, M-O Zahn, A Nusch, T Werner, R Schnell, M Frank, N Hamm, K-U Däßler, C Losem, M Welslau, P Hoevel, K Potthoff, 2022. Weiterlesen Impact of immune checkpoint inhibitors on the management of locally advanced or metastatic non-small cell lung cancer in real-life practice in patients initiating treatment between 2015 and 2018 in France and Germany. F Griesinger, M Pérol, N Girard, I Durand-Zaleski, S Zacharias, L Bosquet, M Jänicke, X Quantin, A Groth, A Fleitz, A Calleja, S Patel, L… Weiterlesen